<DOC>
	<DOCNO>NCT00246337</DOCNO>
	<brief_summary>The purpose study investigate efficacy safety MK 0974 migraine headache identify appropriate dose range study .</brief_summary>
	<brief_title>A Dose-Finding Study MK0974 Acute Migraine ( MK0974-004 )</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Rizatriptan</mesh_term>
	<criteria>Patient least 1 year history migraine ( without aura ) Females childbearing year must use acceptable contraception throughout trial Patient general good health base screen assessment Patient pregnant/breastfeeding ( female expect conceive study period ) Patient heart disease , uncontrolled hypertension ( high blood pressure ) , uncontrolled diabetes significant disease Patient major depression , pain syndrome might interfere study assessment , psychiatric condition , dementia , significant neurological disorder ( migraine ) Patient history gastric small intestinal surgery disease cause malabsorption Patient history cancer within last 5 year</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>